Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBTAX vs BIB overlap: 26% of top holdings shared

Bottom line

How much do FBTAX and BIB overlap?

26% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 26.4% of FBTAX's assets and 22.1% of BIB's. They are substantially different portfolios, so owning both adds real diversification.

BIB holds far more positions (267 vs 129), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBTAXBIB
Weight overlap (top 25)26%
Shared holdings9
Weight in shared holdings26.4%22.1%
Total positions129267
Expense ratio0.94%0.95%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FBTAX and BIB have in common

Holding% of FBTAX% of BIBOverlap
Gilead Sciences Inc5.70%4.66%4.66%
Alnylam Pharmaceuticals Inc3.62%2.01%2.01%
Insmed Inc3.05%1.16%1.16%
Revolution Medicines Inc3.00%1.57%1.57%
Argenx Se3.00%1.19%1.19%
Biogen Inc2.71%1.44%1.44%
Amgen Inc2.37%4.48%2.37%
Moderna Inc1.60%0.94%0.94%
Vertex Pharmaceuticals Inc1.39%4.65%1.39%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBTAX

  1. Abbvie Inc — 14.71%
  2. Spyre Therapeutics Inc — 3.83%
  3. Dianthus Therapeutics Inc — 3.55%
  4. Cogent Biosciences Inc — 3.25%
  5. Oruka Therapeutics Inc — 3.24%
  6. Ascendis Pharma A/s — 2.99%
  7. Mbx Biosciences Inc — 2.45%
  8. Amylyx Pharmaceuticals Inc — 2.25%
  9. Vaxcyte Inc — 1.97%
  10. Fidelity Revere Street Trust — 1.96%
  11. Relay Therapeutics Inc — 1.58%
  12. Viridian Therapeutics Inc — 1.53%
  13. Natera Inc — 1.43%
  14. Kiniksa Pharmaceuticals International Plc — 1.41%
  15. Enliven Therapeutics Inc — 1.25%

Only in BIB

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. N/a — 3.94%
  4. N/a — 3.26%
  5. Regeneron Pharmaceuticals, Inc. — 3.21%
  6. N/a — 2.62%
  7. Repurchase Agreement — 1.28%
  8. Illumina, Inc. — 1.25%
  9. United Therapeutics Corp. — 1.22%
  10. Royalty Pharma plc — 1.20%
  11. N/a — 1.18%
  12. Roivant Sciences Ltd. — 1.08%
  13. Incyte Corp. — 0.97%
  14. Viatris, Inc. — 0.94%
  15. Guardant Health, Inc. — 0.85%

Asset mix

Asset typeFBTAXBIB
Stocks98.2%63.0%
Equity derivatives—16.0%
Other—6.8%
Repurchase agreements—3.1%
Cash & short-term funds2.4%0.8%
Preferred stock1.5%—
Bonds0.1%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFBTAXBIB
US87.8%79.8%
NL4.3%1.6%
DK3.0%0.8%
KY1.8%0.4%
GB1.8%1.7%
CA1.4%0.6%
BM1.2%1.1%
IE—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FBTAX and BIB overlap?
About 26% by weight. 9 securities appear in both funds' top 25 holdings; they make up 26.4% of FBTAX's assets and 22.1% of BIB's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FBTAX and BIB have in common?
The largest shared holdings are Gilead Sciences Inc, Amgen Inc, Alnylam Pharmaceuticals Inc, Revolution Medicines Inc, Biogen Inc.
Should I own both FBTAX and BIB?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FBTAX or BIB?
BIB is broader, with 267 positions versus 129 for FBTAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.